Aarti Drugs expands anti-diabetic capacity

24 Oct 2019 Evaluate

Aarti Drugs has recently expanded its anti-diabetic capacity and currently scaling up its production quantities for the same. Further, brown field CAPEX would be done in the current financial year to expand few capacities in anti-inflammatory therapeutic category.

Aarti Drugs is engaged in the business of manufacturing generic bulk actives, advanced intermediates and specialty chemicals.

Aarti Drugs Share Price

375.20 1.00 (0.27%)
06-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1694.70
Dr. Reddys Lab 1241.15
Cipla 1330.80
Zydus Lifesciences 887.85
Lupin 2168.35
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×